Rosty Raykov, Director at FENNEC PHARMACEUTICALS INC. (FENC), sold 10,946 shares at $6.31 ($69K) on 2026-04-01, disclosed to the SEC on 2026-04-02.
Scheduled sale ($69k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| FENC | SELL | 2026-07-02 | $100K | — | Filing → |
| FENC | SELL | 2026-06-02 | $94K | — | Filing → |
| FENC | SELL | 2026-05-01 | $70K | — | Filing → |